A previous study suggests that a brain-penetrant ACE inhibitor, Captopril, reduces AD symptoms in the mouse AD model (Tg2576) which overexpresses a Swedish APP mutation (KM670/671NL) [46]. The gene discussed is APP; the disease is Alzheimer disease.